In Brief: Kramer Labs
This article was originally published in The Tan Sheet
Executive Summary
Kramer Labs: Decides not to pursue monograph status for its Charcoal Plus activated charcoal as an OTC digestive aid, according to a communication with FDA. Kramer had been planning a clinical trial to support the efficacy of activated charcoal ("The Tan Sheet" May 9, 1994, p. 10)...
Kramer Labs: Decides not to pursue monograph status for its Charcoal Plus activated charcoal as an OTC digestive aid, according to a communication with FDA. Kramer had been planning a clinical trial to support the efficacy of activated charcoal ("The Tan Sheet" May 9, 1994, p. 10).... |